Dewar P J, Wilkinson R, Elliott R W, Ward M K, Kerr D N, Kenward D H, Proud G, Taylor R M
Br Med J (Clin Res Ed). 1982 Mar 13;284(6318):779-82. doi: 10.1136/bmj.284.6318.779.
Graft survival after 348 consecutive first cadaver-donor renal transplants was significantly improved by HLA matching when recipients who had received pretransplant blood transfusions were matched with their kidney donor for two HLA-B locus antigens. No other type of HLA matching significantly improved graft survival in transfused recipients nor did any type of HLA matching in non-transfused recipients. Matching for one HLA-DR antigen had no benefit in transfused recipients. Only two patients received kidneys matched for both DR antigens and only two of those in whom DR matching had been performed had not been transfused. These results indicate that pretransplant blood transfusion and selection of graft recipients predominantly on the basis of HLA-B matching has significantly reduced the renal graft rejection rate in Newcastle upon Tyne over two years. Thus, HLA-B antigen matching should be adopted as the main criterion for kidney sharing between transplant centres.
在348例连续进行的首例尸体供肾肾移植中,当接受过移植前输血的受者与肾脏供者在两个HLA - B位点抗原上相匹配时,通过HLA配型可显著提高移植肾的存活率。在接受过输血的受者中,其他类型的HLA配型均未显著提高移植肾存活率;在未输血的受者中,任何类型的HLA配型也未达到这一效果。在接受过输血的受者中,匹配一个HLA - DR抗原并无益处。仅有两名患者接受了两个DR抗原均匹配的肾脏,且在进行DR配型的患者中,仅有两名未接受过输血。这些结果表明,在泰恩河畔纽卡斯尔,移植前输血以及主要基于HLA - B配型来选择移植受者,在两年内显著降低了肾移植排斥率。因此,HLA - B抗原配型应作为移植中心之间肾脏分配的主要标准。